REDIRECT THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Dec 2025)
What this means for you
This application is over — abandoned 15 Dec 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98620903
- Mark type
- Stylized text
- Filed
- 26 Jun 2024
- Published for opposition
- 18 Mar 2025
- Abandoned
- 15 Dec 2025
- Attorney of record
- Theodore J. Bielen, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer; Chemical reagents for medical purposes
- Class 042 — Scientific and technological services: Medical and scientific research in the field of analysis and treatment of multiple tumor-associated antigens utilizing T-Cell Engagers
Owner
- Affini-T Therapeutics, Inc., Watertown, MA, US
- Affini-T Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 15 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 13 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jan 2025 — NON-FINAL ACTION E-MAILED
- 23 Jan 2025 — NON-FINAL ACTION WRITTEN
- 16 Jan 2025 — ASSIGNED TO EXAMINER
- 14 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED